GlassScriptPhysician profile
Konark Malhotra
NPI 1831479633
$958.95
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $14.05 · 2022: $167.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $193.27 | 2019 | |
| Eisai INC. | $159.36 | 2019 | |
| Viz.Ai, INC. | $139.44 | 2022 | |
| Greenwich Biosciences, INC. | $124.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $115.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $79.02 | 2019 | |
| Lilly USA, LLC | $72.22 | 2019 | |
| Genentech USA, INC. | $27.53 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.37 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.70 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.05 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Konark Malhotra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.